In our last blog, Dr. John Douglas discussed Coronary Artery Disease (CAD). Now, we will cover a new procedure to treat CAD, called Hybrid Revascularization, that we are performing at the Emory Heart & Vascular Center.
Currently, Emory is one of the few centers in the country offering this procedure. Standard guidelines call for patients with blockages in the left main artery (the artery that provides most of the blood to the heart) to undergo bypass surgery.
Hybrid revascularization’s advantage is a combination of coronary artery bypass surgery (CABG) and percutaneous coronary intervention (PCI). Emory physicians are leaders in performing these procedures “off-pump” in a minimally invasive fashion, without breaking open the chest.
The minimally invasive CABG procedure uses robotic-assisted techniques that allow surgery to be performed using small incisions between the ribs rather than through a midline incision dividing the sternum.
The recovery from robotic assisted CABG is shorter and expected to have fewer complications. Impressively, most patients are able to leave the hospital within three to four days and return to full activity, including work, in two to three weeks rather than the two-month recovery generally required following traditional CABG.
This approach is a “best of both worlds strategy”- minimally invasive off-pump left internal mammary artery (LIMA) graft plus a stent placed via ultrasound from the left main to the left circumflex artery.
For more a case study about this procedure view the March issue of The Chamber, our heart and vascular e-newsletter.
About Dr. Halkos
Dr. Halkos is a cardiothoracic surgeon at the Emory Heart & Vascular Center. He specializes in cardiovascular disease, coronary artery bypass surgery and valve repair/replacement. He finished his Medical School, Residency and Fellowship at Emory University School of Medicine. He is a member of the American Medical Association.